AVGO
54
12
WYNN
50
2
MHK
43
-2
AIG
77
2
ALL
56
2
BMY
76
2
PAYX
30
-2
PRU
62
2
FITB
75
2
EQIX
64
5
FLS
61
13
AVB
34
-3
NWS
60
2
RCL
68
4
ITW
37
-2
PYPL
52
2
MMM
56
2
AME
72
6
NTAP
59
4
INTU
60
-3
AVGO
54
12
WYNN
50
2
MHK
43
-2
AIG
77
2
ALL
56
2
BMY
76
2
PAYX
30
-2
PRU
62
2
FITB
75
2
EQIX
64
5
FLS
61
13
AVB
34
-3
NWS
60
2
RCL
68
4
ITW
37
-2
PYPL
52
2
MMM
56
2
AME
72
6
NTAP
59
4
INTU
60
-3
Financhill
Back

First Trust NASDAQ-100-Technology Sector Index Fd Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
70

QTEC
First Trust NASDAQ-100-Technology Sector Index Fd

Last Price:
$233.43
Seasonality Move:
2.02%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Buy
70
First Trust NASDAQ-100-Technology Sector Index Fd (QTEC) is a Buy

Is First Trust NASDAQ-100-Technology Sector Index Fd a Buy, Sell or Hold?

  • The current First Trust NASDAQ-100-Technology Sector Index Fd [QTEC] share price is $233.46. The Score for QTEC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • QTEC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QTEC Stock Price Chart

What is First Trust NASDAQ-100-Technology Sector Index Fd's stock price today?

  • The First Trust NASDAQ-100-Technology Sector Index Fd share price today is $233.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QTEC is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

QTEC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 43.33 Buy
Relative Strength Index (14 RSI): 51.66 Buy
Chaikin Money Flow: 142367 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (222.55 - 237.27) Buy
Bollinger Bands (100): (215.77 - 236.27) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

QTEC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 233.54 Sell
20-day SMA: 231.9 Buy
50-day SMA: 232.82 Buy
200-day SMA: 208.9 Buy
8-day EMA: 122.02 Buy
20-day EMA: 59.67 Buy
50-day EMA: 26 Buy
200-day EMA: 6.79 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

First Trust NASDAQ-100-Technology Sector Index Fd Earnings Growth & QTEC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

First Trust NASDAQ-100-Technology Sector Index Fd Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):